This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

AbCellera to Present at Upcoming Investor Conferences in May and June 2026

AbCellera Biologics Inc. - Business Wire - Thu May 7, 3:05PM CDT

AbCellera (Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:

  • Bank of America Health Care Conference, May 13, 2026
  • Jefferies Global Healthcare Conference in New York, June 4, 2026

A live audio webcast of each presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website closer to date. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc .

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody-based medicines in the areas of endocrinology, women’s health, immunology, oncology, and more. For more information, please visit www.abcellera.com .

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).